Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
84.2 GBX | +3.31% | +2.93% | -2.43% |
Mar. 12 | Target Healthcare interim net asset value and contractual rent grow | AN |
Mar. 12 | Target Healthcare REIT Swings to Fiscal H1 Profit | MT |
Sales 2024 * | 71.4M 90.05M | Sales 2025 * | 73.17M 92.28M | Capitalization | 522M 659M |
---|---|---|---|---|---|
Net income 2024 * | 64M 80.72M | Net income 2025 * | 65M 81.98M | EV / Sales 2024 * | 10.5 x |
Net Debt 2024 * | 231M 291M | Net Debt 2025 * | 256M 323M | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 * |
8.02
x | P/E ratio 2025 * |
8
x | Employees | - |
Yield 2024 * |
6.77% | Yield 2025 * |
6.93% | Free-Float | 99.9% |
1 day | +3.31% | ||
1 week | +2.93% | ||
Current month | +8.23% | ||
1 month | +8.65% | ||
3 months | -3.00% | ||
6 months | +15.18% | ||
Current year | -2.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | - | |
Gordon Bland
DFI | Director of Finance/CFO | 45 | - |
John Flannelly
CIO | Chief Investment Officer | 49 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vince Niblett
BRD | Director/Board Member | - | 21-08-24 |
Richard Cotton
BRD | Director/Board Member | 68 | 22-10-31 |
Michael Brodtman
BRD | Director/Board Member | 64 | 22-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 84.2 | +3.31% | 2,599,189 |
24-03-27 | 81.5 | -1.81% | 5,643,087 |
24-03-26 | 83 | +0.73% | 950,953 |
24-03-25 | 82.4 | -0.72% | 1,500,072 |
24-03-22 | 83 | +1.47% | 610,273 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.43% | 660M | |
-0.89% | 26.32B | |
+3.19% | 23.95B | |
+4.40% | 21.79B | |
-3.79% | 16B | |
-1.26% | 15.72B | |
-2.14% | 15.36B | |
+2.28% | 13.47B | |
-2.30% | 12.32B | |
-8.70% | 12.01B |